Follow
Alvaro Arjona-Sanchez
Alvaro Arjona-Sanchez
Surgeon PhD
Verified email at juntadeandalucia.es
Title
Cited by
Cited by
Year
Design of virtual reality systems for education: A cognitive approach
A Sanchez, J María Barreiro, V Maojo
Education and information technologies 5, 345-362, 2000
2172000
Colorectal peritoneal metastases: Optimal management review
JM Sánchez-Hidalgo, L Rodríguez-Ortiz, Á Arjona-Sánchez, ...
World journal of gastroenterology 25 (27), 3484, 2019
962019
Gastrointestinal stromal tumors: a multidisciplinary challenge
JM Sanchez-Hidalgo, M Duran-Martinez, R Molero-Payan, S Rufian-Peña, ...
World journal of gastroenterology 24 (18), 1925, 2018
942018
HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for …
A Arjona-Sánchez, P Barrios, E Boldo-Roda, B Camps, ...
BMC cancer 18, 1-8, 2018
882018
Conservative management of perforated duodenal diverticulum: a case report and review of the literature
D Martínez-Cecilia, A Arjona-Sánchez, M Gómez-Álvarez, ...
World journal of gastroenterology: WJG 14 (12), 1949, 2008
852008
Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: long-term outcomes and perspectives from a high-volume center
FC Muñoz-Casares, FJ Medina-Fernández, Á Arjona-Sánchez, ...
European Journal of Surgical Oncology (EJSO) 42 (2), 224-233, 2016
572016
Mark-recapture of Monochamus galloprovincialis with semiochemical-baited traps: population density, attraction distance, flight behaviour and mass trapping …
LM Torres-Vila, C Zugasti, JM De-Juan, MJ Oliva, C Montero, FJ Mendiola, ...
Forestry: An International Journal of Forest Research 88 (2), 224-236, 2015
452015
LC–MS/MS quantitative analysis of paclitaxel and its major metabolites in serum, plasma and tissue from women with ovarian cancer after intraperitoneal chemotherapy
MA Fernández-Peralbo, F Priego-Capote, MDL De Castro, ...
Journal of Pharmaceutical and Biomedical Analysis 91, 131-137, 2014
452014
Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: an overview
A Arjona-Sánchez, FJ Medina-Fernández, FC Muñoz-Casares, ...
World journal of gastrointestinal oncology 6 (10), 407, 2014
442014
Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study
FC Muñoz-Casares, S Rufián, Á Arjona-Sánchez, MJ Rubio, R Díaz, ...
Cancer chemotherapy and pharmacology 68, 267-274, 2011
422011
Postoperative time course and utility of inflammatory markers in patients with ovarian peritoneal carcinomatosis treated with neoadjuvant chemotherapy, cytoreductive surgery …
FJ Medina Fernández, FC Munoz-Casares, A Arjona-Sanchez, ...
Annals of surgical oncology 22, 1332-1340, 2015
412015
A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of …
A Arjona-Sanchez, J Esquivel, O Glehen, G Passot, KK Turaga, D Labow, ...
Surgical endoscopy 33, 854-860, 2019
402019
Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced colon cancer: a phase 3 randomized clinical trial
A Arjona-Sánchez, E Espinosa-Redondo, A Gutiérrez-Calvo, ...
JAMA surgery 158 (7), 683-691, 2023
332023
RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis …
A Arjona-Sanchez, L Rodriguez-Ortiz, D Baratti, MA Schneider, ...
Annals of surgical oncology 26, 2595-2604, 2019
312019
Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances
A Arjona-Sánchez, A Cadenas-Febres, J Cabrera-Bermon, ...
European Journal of Surgical Oncology (EJSO) 42 (6), 869-876, 2016
302016
Long-term survival with peritoneal mucinous carcinomatosis from intraductal mucinous papillary pancreatic carcinoma treated with complete cytoreduction and hyperthermic …
A Arjona-Sanchez, C Muñoz-Casares, R Ortega-Salas, A Casado-Adam, ...
International Journal of Hyperthermia 30 (6), 408-411, 2014
282014
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug
E Alors-Perez, R Blázquez-Encinas, S Alcalá, C Viyuela-García, ...
Journal of Experimental & Clinical Cancer Research 40, 1-21, 2021
272021
Uterine leiomyosarcoma metastasis to the pancreas: report of a case and review of the literature
J Alonso Gómez, Á Arjona Sánchez, D Martínez Cecilia, R Díaz Nieto, ...
Journal of gastrointestinal cancer 43, 361-363, 2012
272012
GECOP-MMC: Phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical …
F Pereira, A Serrano, I Manzanedo, E Pérez-Viejo, S González-Moreno, ...
BMC cancer 22 (1), 536, 2022
262022
Effects of capecitabine and celecoxib in experimental pancreatic cancer
Á Arjona-Sánchez, J Ruiz-Rabelo, MD Perea, R Vázquez, A Cruz, ...
Pancreatology 10 (5), 641-647, 2010
262010
The system can't perform the operation now. Try again later.
Articles 1–20